K

Kindly MD Inc
NASDAQ:KDLY

Watchlist Manager
Kindly MD Inc
NASDAQ:KDLY
Watchlist
Price: 10.9 USD -5.71% Market Closed
Market Cap: 120.8m USD
Section:
 

Relative Value

The Relative Value of one KDLY stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.9 USD, Kindly MD Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KDLY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

48.9
P/S
P/S
Price to Sales
48.9
vs History
9
vs Industry
28
Median 3Y
8.8
Median 5Y
8.8
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
22.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-18.1
Median 5Y
-18.1
Industry
14.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
11
Median 3Y
-12.4
Median 5Y
-12.4
Industry
21.4
More Details
79
P/B
P/B
Price to Book Value
79
vs History
9
vs Industry
22
Median 3Y
9.4
Median 5Y
9.4
Industry
2.3
More Details
48.4
EV/S
EV/S
Enterprise Value to Sales
48.4
vs History
9
vs Industry
33
Median 3Y
7.8
Median 5Y
7.8
Industry
2.6
More Details
50.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
50.1
vs History
9
vs Industry
54
Median 3Y
8.2
Median 5Y
8.2
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-9.5
Industry
12.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
17.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-14.4
Median 5Y
-14.4
Industry
14.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-14.3
Median 5Y
-14.3
Industry
18.8
More Details
113.2
EV/IC
EV/IC
Enterprise Value to IC
113.2
vs History
22
vs Industry
2
Median 3Y
113.2
Median 5Y
113.2
Industry
1.9
More Details

Multiples Across Competitors

KDLY Competitors Multiples
Kindly MD Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Kindly MD Inc
NASDAQ:KDLY
120.8m USD 48.9 -27.6 -29.5 -28.5
US
CVS Health Corp
NYSE:CVS
99.8B USD 0.3 212.8 14 14
US
Cigna Corp
NYSE:CI
72.6B USD 0.3 11.8 7.6 9.7
US
Cigna Group
XMUN:CGN
63.6B EUR 0.3 12 7.7 9.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.1B EUR 1.3 24.6 10.7 16.2
DE
Fresenius Medical Care AG
XMUN:FME
21.8B EUR 1.1 30.3 9.7 20.8
US
Laboratory Corporation of America Holdings
NYSE:LH
22.5B USD 1.6 26.3 14.2 19.8
US
Quest Diagnostics Inc
NYSE:DGX
21B USD 1.9 21.8 12 16.1
US
Guardant Health Inc
NASDAQ:GH
14B USD 15.5 -35.2 -37 -33.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.9B EUR 0.6 15.1 6.1 13.1
US
DaVita Inc
NYSE:DVA
7.4B USD 0.6 9.6 6.4 8.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
K
Kindly MD Inc
NASDAQ:KDLY
Average EV/EBITDA: 9.8
Negative Multiple: -29.5 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
25%
0.6
US
Cigna Corp
NYSE:CI
7.6
5%
1.5
US
C
Cigna Group
XMUN:CGN
7.7
5%
1.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.7
14%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
9.7
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14.2
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
12
8%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -37 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.1
10%
0.6
US
DaVita Inc
NYSE:DVA
6.4
4%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
K
Kindly MD Inc
NASDAQ:KDLY
Average EV/EBIT: 14.2
Negative Multiple: -28.5 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
19%
0.7
US
Cigna Corp
NYSE:CI
9.7
5%
1.9
US
C
Cigna Group
XMUN:CGN
9.8
5%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.2
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
20.8
25%
0.8
US
Laboratory Corporation of America Holdings
NYSE:LH
19.8
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
16.1
11%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33.6 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.1
25%
0.5
US
DaVita Inc
NYSE:DVA
8.7
4%
2.2

See Also

Summary
KDLY intrinsic value, competitors valuation, and company profile.
DCF Valuation
KDLY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KDLY stock valuation using valuation multiples.
Wall Street Estimates
KDLY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KDLY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.